Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
M. Dreyling(Ludwig-Maximilians-Universität München), Marco Ladetto(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Hanneke C. Kluin‐Nelemans(University Medical Center Groningen), Jan Walewski(The Maria Sklodowska-Curie National Research Institute of Oncology), Steven Le Gouill(Inserm), Simon Rule(AstraZeneca (United Kingdom)), Olivier Hermine(Centre National de la Recherche Scientifique), Ofer Shpilberg(Texas Oncology), Carsten Geisler(University of Copenhagen)
Cited by 136
Related Papers
Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.
|Journal of Clinical Oncology|1997|1.3k
Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2015|920